Results 11 to 20 of about 26,281 (176)

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source

Stereotactic Body Radiotherapy for Prostate Cancer

American Journal of Men's Health, 2020
Prostate cancer remains the most common and second most deadly cancer diagnosed amongst U.S. men. External beam radiotherapy is a standard-of-care definitive treatment option for localized prostate cancer and historically constituted an 8–9-week ...
Neil R. Parikh M.D., Amar U. Kishan M.D.
doaj   +1 more source

Stereotactic Body Radiotherapy for Treatment of Squamous Cell Carcinoma of the Tongue Base Associated with Human Papilloma Virus

Frontiers in Oncology, 2013
Stereotactic body radiotherapy has emerged as a treatment for recurrent squamous cell carcinoma of the head and neck in the field of prior radiation. We report a case of its use in an HPV positive patient with squamous cell carcinoma of the right base ...
Brian Craig Rodgers, Prakash eNeupane, Christopher eLominska, Yelizaveta eShnayder   +3 more
doaj   +1 more source

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients

Frontiers in Oncology
IntroductionProstate cancer is the fourth most commonly diagnosed cancer among men worldwide. Various tools are used to manage disease such as conventional radiotherapy.
Youssef Slama, Gilles Baumont, Angelique Arcambal, Mickael Begue, Olivier Maillot, Rima Sayah, Romain Castanet, Raoul Caboche, Pedro Liberati, Hakim Slaoui, Medi Bouaziz, Olivier Borson, Nam P. Nguyen, Fabien Dutheil   +13 more
doaj   +1 more source

The changing role of radiation therapy in the management of oligometastatic disease

Technical Innovations & Patient Support in Radiation Oncology, 2017
It is clear from surgical series that there are selected patients presenting with localised metastatic disease who can be cured by radical ablation of the metastasis.
H. Tharmalingham, P.J. Hoskin
doaj   +1 more source

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets

Journal of Medical Physics, 2021
The primary purpose of the study is to evaluate the implementation of Helical TomoTherapy (HT) for eligible stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy (SRS/SBRT/SABR) cases using TomoEDGE option. The study
N V. N. Madhusudhana Sresty, A Krishnam Raju, G Deleep Kumar, S Rohit, B Nagarjuna Reddy, V C Sahithya, B Devender Reddy, Yakub Mohd, Tasneem Rushdi, Harjoth Bajwa, S Aparna   +10 more
doaj   +1 more source

Elimination of refractory ventricular tachycardia storm and fibrillation using stereotactic radiotherapy

Clinical Case Reports, 2023
Ventricular tachycardia storm is a potentially lethal condition with limited treatment options. Failed ablation is associated with a fourfold mortality increase in this population. Stereotactic body radiotherapy was proposed in these cases.
Alexander Wutzler, Borris Tiedke, Mohamed Osman, Noha Mahrous, Reinhard Wurm   +4 more
doaj   +1 more source

Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial

Clinical and Translational Radiation Oncology, 2023
Predictors of genitourinary toxicity after post-prostatectomy radiotherapy remain elusive. A previously defined germline DNA signature (PROSTOX) has shown predictive ability for late grade ≥ 2 GU toxicity after intact prostate stereotactic body ...
Amar U. Kishan, Nicholas Marco, Ting Martin Ma, Michael L. Steinberg, Ankush Sachdeva, Minsong Cao, Leslie K. Ballas, Emily Rietdorf, Donatello Telesca, Joanne B. Weidhaas   +9 more
doaj   +1 more source

Guidelines for Pediatric Radiotherapy Simulation: A Report From the Children's Oncology Group Radiation Oncology Discipline

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric radiation therapy presents unique challenges compared to adult treatments, including those of immobilization, potential need for sedation, and the critical importance of accurate, reproducible positioning. Additionally, heightened attention to imaging doses is necessary to minimize long‐term toxicity in survivors.
Parham Alaei, Stephen Mihalcik, Sujith Baliga, Young Kwok, Dana Casey, Eric Ehler, Christiane Burton, John C. Breneman, Daphne A. Haas‐Kogan, Suzanne L. Wolden, Arnold C. Paulino, Nadia N. Laack, Natia Esiashvili, Sarah Milgrom, Christine Hill‐Kayser, Thomas J. Fitzgerald, John A. Kalapurakal, Chia‐Ho Hua   +17 more
wiley   +1 more source

Prostate Cancer Stereotactic Body Radiation Therapy with Image-guided Radiation Therapy (IGRT) Technique with Three-Dimensional Transperineal Ultrasound for IGRT Tracking of the Prostate

Brazilian Journal of Oncology
Introduction Ultrahypofractionated radical radiotherapy for prostate cancer, also known as stereotactic body radiation therapy (SBRT), is an unprecedented modality of prostate radiotherapy and is still used very sparsely in Brazil.
Igor Migowski, Arn Migowski
doaj   +1 more source